Gilchrist, I C <br/><br/>
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.  [electronic resource] 

 -  Circulation  Jul 2001 
 - 406-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/hc2901.093504  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary<br/>Area Under Curve<br/>Dose-Response Relationship, Drug<br/>Eptifibatide<br/>Female<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Peptides--pharmacokinetics<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacokinetics<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Time Factors